VS Health Group

What VS Health Group does

VS Health Group is a US-based market access consultancy serving pharmaceutical and biotechnology manufacturers, headquartered at 28 Andover Street, Andover, MA. The firm delivers services across three integrated pillars — Value and Insights, Commercial Planning, and Stakeholder Engagement — spanning early-phase due diligence, payer value proposition development, launch and lifecycle planning, payer/PBM engagement, and outsourced field account management. It is positioned as the 'only vertically integrated market access consulting company' that works across clinical trial design, business planning, and field execution, with proprietary capability claimed in real-time payer intelligence drawn from its Viking Payer Engagement field team.

The company traces its origin to Viking Healthcare Solutions, founded in 1998 by Bill Finneran — described as the first outsourced market access team in the industry — and was rebranded to VS Health Group with Jeffrey Martini as CEO and subsequently Chairman, and Dawn Rich elevated to CEO in July 2025. The leadership bench is composed almost entirely of former senior payer and pharma executives, with backgrounds at Genentech, Novartis, Shire, Express Scripts, Highmark, CVS Health/PBM, Pfizer, Kronos Bio, Dynavax, and Avalere/Fishawack (via the prior Skysis platform). Select disclosed engagements include market access and reimbursement strategy support for Novartis portfolio challenges and product launch playbooks for Shire.

The business model is professional services: bespoke consulting and managed services engagements sold directly to enterprise pharmaceutical and biotech clients, with a stated horizontal segmentation spanning manufacturers (primary), health plans, and PBMs (secondary). Pricing is not publicly disclosed. Capital structure reflects founder-controlled operation with limited external capital — the only filing disclosed is an April 2024 SEC Form D for $240,000 of equity in a Delaware entity described as 'yet to be formed.' Marketing is executed through a content hub (vshealthgroup.com), LinkedIn, industry conference participation at Asembia and AMCP, and issued press releases. Operations remain US-domestic with no global footprint claim.

Name

VS Health Group

Legal name

VS Health Group, Inc.

Website

https://vshealthgroup.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

VS Health Group is a US-based market access consultancy serving pharmaceutical and biotech manufacturers with outsourced payer strategy, commercial planning, and field engagement services delivered through a vertically integrated senior practitioner model.

Ownership category

akta.pro rank

Headquarters

HQ city

Andover

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Market Access Consulting Services: VS Health Group generates revenue by providing strategic market access consulting, outsourced payer engagement teams, and advisory services to pharmaceutical and biotech companies. Services span portfolio and product insights, commercial planning, and stakeholder engagement (payer, patient, and HCP). Revenue is derived from professional services engagements with pharma/biotech clients.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

VS Health Group is a vertically-integrated market access consultancy that provides pharmaceutical and biotech manufacturers with end-to-end services spanning Value and Insights (portfolio insights, payer models, market shaping), Commercial Planning (launch and lifecycle planning, cross-functional project management), and Stakeholder Engagement (payer engagement strategy, field account management, patient support programs). The firm supplements strategic consulting with outsourced payer engagement field teams (Viking Payer Engagement) that operate directly on behalf of clients to execute market access playbooks.

Product overview

VS Health Group is a leading vertically integrated market access consultancy in the US that offers a comprehensive suite of consulting services organized around three core pillars: Value and Insights, Commercial Planning, and Stakeholder Engagement. The company provides end-to-end market access solutions spanning early-phase due diligence, evidence value assessment, market shaping, payer engagement strategy, field solutions, and patient support services. VS Health Group operates as a single unified consultancy rather than a platform with modular add-ons, delivering its services through experienced teams of former pharma and payer executives to help pharmaceutical and biotech companies navigate the evolving payer reimbursement landscape.

Differentiator

Problem solved

Functional benefit

Products and services

• Value and Insights Portfolio and product insights enabling informed decision-making and proactive planning for impactful stakeholder engagement strategies, including early-phase due diligence, evidence value and pricing assessment, market shaping (PIE and PVP frameworks), dossier and economic value proposition development, payer health economic models/field tools, and primary/secondary market research for pharmaceutical and biotech manufacturers.
• Commercial Planning Launch and lifecycle planning services for pharmaceutical and biotech manufacturers covering landscape assessments, market access and brand marketing strategy with cross-functional project management, patient services strategy including hub services vendor RFP, environmental analyses and business planning, strategic plan development with payer engagement planning and quarterly business reviews, and contract strategy analysis.
• Stakeholder Engagement Comprehensive stakeholder engagement services for pharmaceutical and biotech brands including payer conference engagement strategy and messaging, hub services and specialty pharmacy vendor implementation, patient access and adherence programs, market access field and sales training, field solutions and account management, market access KPI monitoring, contract strategy implementation and tracking, and brand omnichannel marketing implementation.
• Launch Planning Comprehensive launch planning support for biopharmaceutical companies including market access plan development, budget management, launch readiness project planning, team structure development, data strategy and KPIs, patient support services program development, and market access marketing deliverables.
• Landscape Assessment Market assessment of the payer landscape and payer perspectives on on-market products, including competitor analysis to refine payer strategy and evidence generation plans for pharmaceutical clients.
• Payer Value Proposition Gap Analysis Identification of gaps in payer value proposition and development of new message recommendations to optimize product access for rare disease and specialty products.
• Medical Director Relationship Expansion Strategic engagement services at national payer conferences to establish relationships with medical benefit decision makers and ensure appropriate policy positioning for pharmaceutical clients.
• Strategic Conference Engagement Planning End-to-end conference engagement services for pharma clients including development of tailored playbooks, strategic planning frameworks, custom preparation materials, and structured templates for capturing insights and follow-ups across priority accounts.
• Direct-to-Consumer Drug Program Advisory Multi-perspective analysis of direct-to-consumer prescription drug programs from patient, payer/PBM, and biopharma manufacturer viewpoints, used to inform market access strategies for pharmaceutical clients.
• Transparent PBM Advisory Services Analysis and strategic guidance on the impact of transparent pharmacy benefit managers (PBMs) on market access, covering manufacturer, patient, payer, and PBM perspectives for pharmaceutical clients.
• Viking Payer Engagement Field Team Outsourced payer engagement field team model under the Viking Payer Engagement brand, providing embedded or deployed field teams that execute the market access playbook on behalf of pharmaceutical manufacturer clients and feed real-time payer insights back into strategy iterations.

Quantifiable outcome

• Billion+ in net product revenue realized for clients
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Partnerships

One partnership is on record.

• Close-Up InternationalcoreTechnology or Integration · 1 October 2025Close-Up International, a global AI-powered CRM and business intelligence solutions provider for the life sciences industry, was selected by VS Health Group as its CRM partner to support the company's expanding Market Access and Payer Engagement teams. Close-Up brings over 30 years of pharma CRM experience with 245+ active life science clients across 50+ countries. The partnership was chosen for its deep pharma experience, ability to move quickly, and platform scalability and rapid deployment capabilities. William Finneran, Partner at VS Health Group, noted that the partnership was based on Close-Up's understanding of the unique needs of the business and their ability to deliver industry-specific functionality.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ZS Associates: ZS Associates is a global professional services firm with a dedicated market access and payer strategy practice serving large pharmaceutical manufacturers. Like VS Health Group, it focuses on sales, marketing, and market access advisory for pharma, but at materially greater scale.
• Avalere Health: Avalere Health is a healthcare policy and market access consultancy that acquired Skysis (the prior firm co-founded by VS Health Group's chairman Jeff Martini) in 2020. It is the most directly comparable US market access consulting competitor and represents a likely acquirer profile for VS Health Group.
• Health Advances: Health Advances is a healthcare strategy consulting firm focused on pharma, biotech, and medtech clients, with strong market access and commercial strategy capabilities. It is a comparable boutique competitor serving similar pharma and biotech clients.
• Beghou Consulting: Beghou Consulting is a life sciences commercial consulting firm serving pharmaceutical and biotech manufacturers with expertise in market access, pricing, and commercial analytics. It is a comparable specialty consultancy serving similar enterprise pharma clients.
• Simon-Kucher & Partners: Simon-Kucher is a global consulting firm specializing in pricing, market access, and commercial strategy for pharmaceutical and biotech clients. It is a direct peer in market access advisory with particular strength in pricing and reimbursement strategy similar to VS Health Group's Value and Insights pillar.
• Clearview Healthcare Partners: Clearview Healthcare Partners is a boutique strategy consulting firm focused exclusively on life sciences, with deep market access and commercialization expertise serving biotech and pharma clients. It is a close comparable in size, focus, and client profile.

Broad incumbents

• IQVIA: IQVIA is a global life sciences services and consulting giant with substantial market access and commercialization advisory capabilities serving pharmaceutical and biotech clients. It competes with VS Health Group on pharma market access engagements while offering much broader data, technology, and commercial services.
• Guidehouse: Guidehouse (formerly Navigant Consulting) has a significant life sciences strategy practice serving pharma and biotech manufacturers on market access, commercial, and operational issues. It competes for similar enterprise advisory mandates as VS Health Group at greater scale.
• Fishawack Health: Fishawack Health acquired Avalere Health (and thus Skysis) in 2021, building a global pharma services and consulting platform. It is a peer through its market access consulting heritage and competes for similar pharma manufacturer engagements.
• Charles River Associates: Charles River Associates is a global consulting firm with a Life Sciences practice providing commercial, pricing, and market access strategy for pharmaceutical manufacturers. It competes for similar enterprise advisory mandates at greater scale and breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vshealthgroup

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VS Health Group